✦ LIBER ✦

BIM induction of apoptosis triggered by EGFR-sensitive and resistance cell lines of non-small-cell lung cancer

✍ Scribed by Zhanxia Li; Songwen Zhou; Ling Zhang; Chunxia Su; Jinqin Hang; Yinmin Zhao; Bo Su; Caicun Zhou

Book ID: 107577094
Publisher: Springer US
Year: 2010
Tongue: English
Weight: 293 KB
Volume: 28
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-010-9470-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Apoptosis of non-small-cell lung cancer

Apoptosis of non-small-cell lung cancer cell lines after paclitaxel treatment involves the BH3-only proapoptotic protein Bim

✍ Li, R; Moudgil, T; Ross, H J; Hu, H-M 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 476 KB

Induction of cell apoptosis in non-small

Induction of cell apoptosis in non-small cell lung cancer cells by cyclin A1 small interfering RNA

✍ Nam Hoon Cho; Yoon Pyo Choi; Dong Suk Moon; Haeryoung Kim; Suki Kang; Owen Ding; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 638 KB

Effects of gemcitabine on cell prolifera

Effects of gemcitabine on cell proliferation and apoptosis in non-small-cell lung cancer (NSCLC) cell lines

✍ E. Pace; M. Melis; L. Siena; F. Bucchieri; A. M. Vignola; M. Profita; M. Gjomark 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 337 KB

EGFR inhibition in the treatment of non-

EGFR inhibition in the treatment of non-small cell lung cancer

✍ David E. Gerber 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

Induction of apoptosis of non-small cell

Induction of apoptosis of non-small cell lung cancer by a methylated oligonucleotide targeting survivin gene

✍ Li, H L; Ma, A N 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 362 KB

Establishment of a human non-small cell

Establishment of a human non-small cell lung cancer cell line resistant to gefitinib

✍ Fumiaki Koizumi; Tatsu Shimoyama; Fumiko Taguchi; Nagahiro Saijo; Kazuto Nishio 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 672 KB

## Abstract The epidermal growth factor receptor (EGFR) tyrosine‐kinase inhibitor gefitinib (Iressa®, ZD1839) has shown promising activity preclinically and clinically. Because comparative investigations of drug‐resistant sublines with their parental cells are useful approaches to identifying the m